Health

Bad Data, and Compromised Limits, on Chromium

"This was a 10-year campaign to shape the science to fit the industry's agenda rather than shape the regulation to fit the science," Professor David Michaels said of industry attempts to avoid lower exposure limits for hexavalent chromium. In 2004, the U.S. Occupational Safety and Health Administration (OSHA) proposed reducing the exposure limit set in 1943 more than fifty-fold.

No

Drug Company Reps Take Doctors To The Dogs, Lap-Dancing & Tennis

In late January a comedian hosting the UK Pharmaceutical Marketing Society's Annual Advertising Awards ceremony joked that "twenty years ago it was all lap dancing and champagne for the doctors. These days you're lucky if you can give them a three-star hotel and a f***ing biro." Not so, it seems.

No

Inside the Tobacco Industry's Files

As the Center for Media and Democracy has noted, the tobacco industry pioneered many deceptive public relations tactics, casting a long shadow over science and health reporting, as well as the public's right to know.

Before its fall from grace, tobacco industry created front groups courted journalists and obscured damning scientific evidence. But, inadvertently, the industry is now helping independent researchers and reporters understand how PR is used to obscure facts and shape public debates.

WHO Rejects Corporate-Funded Research Institute

The United Nations' World Health Organization (WHO) barred the U.S.-based International Life Sciences Institute (ILSI) from taking part in "WHO activities setting microbiological or chemical standards for food and water." The decision followed warnings from health, environmental and union groups, including the

No

Environmental Defense or Nanotech Defense?

If you have concerns about the development of nanotechnology, you might want to keep an eye on the 'partnership' between the chemical industry giant DuPont and Environmental Defense (ED), the New York-based environmental group.

The project, according to a joint media release issued in October 2005 by ED's Fred Krupp and DuPont's Chad Halliday, is to "identify, manage and reduce potential health, safety and environmental risks of nano-scale materials across all lifecycle stages." Once developed, the framework will "then be pilot-tested on specific nano-scale materials or applications of commercial interest to DuPont."

To be fair, ED has flagged concerns about there being inadequate health and environmental assessments of nanotechnologies to date. However, ED hasn't mentioned publicly what they think about DuPont and other companies having products that are already on the market without such assessments.

Pages

Subscribe to Health